Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2018 · 10-Q
Revenue$1.57M$1.57M+1.1% vs Q3 2017 Net Income-$151.03K-$151.03KN/M vs Q3 2017 EPS Diluted$0.00$0.00— vs Q3 2017 Gross Profit$1,450,518+10.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$189,700N/M Free Cash Flowderived$186,967N/M Margins · derivedGross margin92.6%+7.5 pt vs Q3 2017
Operating margin-8.4%−6.6 pt vs Q3 2017
Net margin-9.6%−6.5 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end